14.1 Ectopic Pregnancy, Miscarriage Management, and Early Pregnancy Assessment Units (EPAU)
Key Takeaways
For early pregnancy pain or bleeding, assess stability first. Suspected rupture, shock, severe pain or heavy bleeding needs emergency assessment and urgent obstetric/gynaecology involvement. Stable patients can be assessed through the local early pregnancy unit.
Pregnancy of unknown location is a temporary ultrasound classification. Serial beta-hCG about 48 hours apart helps plan surveillance alongside symptoms and expert transvaginal ultrasound. A single value or trend cannot establish location.
In the Irish national example, consider expectant care for a confirmed small tubal ectopic in a stable, pain-free patient with falling beta-hCG below 1,500 IU/L and reliable follow-up. Methotrexate or surgery depends on symptoms, imaging, beta-hCG, contraindications, follow-up and informed preference.
Confirm miscarriage with the applicable Irish ultrasound criteria. Repeat a scan after 7–10 days when the viability of a demonstrated intrauterine pregnancy is uncertain. Treat an empty uterus after bleeding as a pregnancy of unknown location unless an intrauterine pregnancy had previously been confirmed.
Offer anti-D to unsensitised RhD-negative patients undergoing surgery for first-trimester miscarriage or ectopic pregnancy. Follow the Irish condition-specific guidance for non-surgical care.
Early pregnancy assessment
Pregnancy-related pain or bleeding can precede a clear ultrasound diagnosis. Ask about symptom onset and severity, bleeding, dizziness or fainting, and prior pregnancies, treatment, scans and tubal risk factors. Take vital signs and assess abdominal tenderness or peritonism. Test for pregnancy in people of reproductive potential with compatible symptoms, even when contraception is reported.
- Suspected rupture or major haemorrhage: Severe or escalating pain, shoulder-tip pain, collapse, haemodynamic compromise or peritonism requires immediate emergency assessment. Resuscitate while contacting obstetrics/gynaecology and activate the haemorrhage pathway as appropriate. Do not delay urgent surgery to wait for an hCG result.
- Stable suspected early pregnancy complication: Use the local Early Pregnancy Assessment Unit (EPAU) pathway for clinical examination and expert transvaginal ultrasound (TVUS). Consider an early location scan in a subsequent pregnancy after an ectopic. Explain why follow-up matters, provide emergency contact details and ask the patient to return immediately for worsening pain, faintness or heavy bleeding.
For bleeding before six weeks with no pain or ectopic risk factors, the Irish miscarriage guideline allows repeat high-sensitivity urine testing after two weeks. A positive result, persistent bleeding or new pain warrants referral.
Transvaginal ultrasound assesses the uterus, both adnexa and free fluid. The Irish ectopic guideline proposes an approximate beta-hCG range of 1,500–2,000 IU/L to help judge when an intrauterine sac would usually be visible with expert TVUS. Use the local assay and image quality in interpreting the result. An empty uterus above that range warrants careful review for ectopic pregnancy or other outcomes. It does not establish a diagnosis or justify methotrexate by itself.
Severe nausea or vomiting
Consider hyperemesis gravidarum when severe nausea or vomiting begins in early pregnancy, disrupts food and fluid intake and markedly limits daily activity. Dehydration can occur but is unnecessary for diagnosis. Assess oral intake, urine output, weight change, signs of dehydration and relevant comorbidities. The Irish 2026 guideline uses symptom scores such as PUQE-24 to help judge severity. Ketonuria alone does not grade severity or hydration. Consider other causes when onset is later or there is fever, focal pain, a concerning scan or diabetes with risk of ketoacidosis.
Offer dietary and hydration support and appropriate antiemetics. Involve obstetrics if the patient cannot maintain intake, is dehydrated, has marked weight loss, or cannot take essential medication. In significant illness use an individualised day-unit or inpatient plan, including IV isotonic fluid, electrolytes and antiemetics when needed. Replace potassium, magnesium and phosphate as indicated. Give thiamine to patients with severe vomiting, admissions for hyperemesis or prolonged poor intake, before routine dextrose or nutrition support when deficiency is possible. Seek urgent specialist help for metabolic complications.
Pregnancy of unknown location
A pregnancy of unknown location (PUL) is a positive pregnancy test with no intrauterine or extrauterine pregnancy identified on expert TVUS. Possible outcomes are an early intrauterine pregnancy, resolving PUL, ectopic pregnancy or persistent PUL. If the pregnancy is seen within the uterus but its viability is uncertain, follow the separate ultrasound pathway for uncertain viability.
Obtain serum beta-hCG at presentation and about 48 hours later in the stable patient when indicated. Use the same analyser where possible. Interpret symptoms, examination, scan and the trend together.
| Pattern | Interpretation and next step |
|---|---|
| Clear rise | Can represent an early intrauterine pregnancy. For a stable, pain-free patient the Irish algorithm uses a rise above 66% as a likely intrauterine pattern, with follow-up TVUS. Even an apparently appropriate rise can occur with an ectopic pregnancy. Locate the pregnancy on follow-up. |
| Substantial fall | Suggests a resolving pregnancy. The Irish example treats a fall greater than 50% as likely resolving and uses a timed urine test or further serum testing depending on the second level. Follow the local instructions through resolution. |
| Slow rise, plateau or small fall | Increased ectopic concern in the Irish algorithm. Review symptoms and arrange further serum testing and TVUS as appropriate. Involve a senior clinician by the third serum test and earlier if clinically concerning. |
The Irish guideline permits local approaches including validated prediction tools. A low-risk pattern still needs documented follow-up, with earlier review if symptoms develop. A urine test can be part of follow-up for selected falling patterns. A negative urine result does not directly measure the serum concentration.
Recognising ectopic pregnancy
An ectopic pregnancy implants outside the normal endometrial cavity. Most are tubal, commonly ampullary. Interstitial pregnancy implants in the part of the tube crossing the uterine muscle. Other sites include the cervix, ovary, a caesarean scar, a rudimentary uterine horn and the abdomen. These sites need expert localisation and individualised management. An intrauterine pregnancy with a simultaneous extrauterine pregnancy is heterotopic pregnancy. Keep this possibility in mind after assisted reproduction when symptoms or adnexal findings persist.
Prior ectopic pregnancy, tubal surgery or disease, pelvic inflammatory disease, infertility treatment and smoking increase concern. If a patient becomes pregnant with an intrauterine contraceptive device in situ, actively confirm location. Contraception lowers the overall risk of pregnancy. Some patients with ectopic pregnancy have no known risk factor.
Unilateral lower abdominal pain, vaginal bleeding or a missed period can be clues. Shoulder-tip pain or syncope can accompany intraperitoneal bleeding. On TVUS, an extrauterine gestational sac with a yolk sac or embryo confirms ectopic pregnancy. An adnexal mass moving separately from the ovary is suspicious and needs careful expert interpretation, including distinction from the corpus luteum. Look for free fluid and reconsider urgently when pain or haemodynamic status changes.
Choosing treatment for tubal ectopic pregnancy
Discuss the diagnosis and management with a consultant. Consider symptoms, ultrasound, hCG, follow-up, fertility, contraindications and the patient's preferences. Provide clear plans for follow-up and reattendance.
| Option | Irish clinical decision and follow-up |
|---|---|
| Expectant care | Consider a haemodynamically stable, pain-free patient with falling beta-hCG below 1,500 IU/L, a mass under 3 cm and ability to return. The Irish guideline describes checking about every 48 hours until the falling pattern is established over three results, then weekly to below 5 IU/L. Reassess new pain or a plateau or rise promptly. |
| Methotrexate | An option for a confirmed unruptured ectopic when beta-hCG is below 5,000 IU/L, there is no significant pain, haemoperitoneum or embryonic cardiac activity, there are no contraindications, and follow-up is feasible. The Irish guideline notes the highest success at or below 3,000 IU/L and lists a mass above 3 cm among grounds for surgery. Check full blood count, kidney and liver function, medicines and breastfeeding status before prescribing. |
| Surgery | Urgent for suspected rupture or haemodynamic instability. Also appropriate for significant pain, embryonic cardiac activity, a mass above 3 cm, beta-hCG above 5,000 IU/L, unsuitable or unsuccessful medical care, inability to return, or patient preference. Discuss boundary cases with the consultant. Laparoscopy is preferred when stable and feasible. Use the operative approach that safely controls haemorrhage in an emergency. |
The Irish single-dose regimen is IM methotrexate 50 mg/m². For example, a body surface area of 1.60 m² gives 80 mg before any local rounding rule. Measure beta-hCG on days 4 and 7. A fall of less than 15% between those days requires reassessment, with repeat imaging, a further dose or surgery according to findings. When there is an adequate fall, check weekly to below 5 IU/L. Rupture can occur during follow-up. Explain when to seek emergency care and advise avoiding conception for three months after methotrexate on the Irish ectopic pathway.
Salpingectomy is usually offered if the other tube is healthy and no other fertility factor suggests benefit from conserving the affected tube. Consider salpingostomy when fertility is at risk. Persistent trophoblast after salpingostomy requires weekly hCG follow-up to resolution and may require further treatment. Offer follow-up and bereavement support, and arrange early ultrasound at about six weeks in the next pregnancy.
First-trimester miscarriage
| Finding | Clinical interpretation |
|---|---|
| Vaginal bleeding, intrauterine pregnancy seen, no confirmed loss | Threatened miscarriage is possible. Assess viability and provide advice and follow-up. |
| Bleeding, open cervical os and a demonstrated intrauterine gestation | Suggests inevitable miscarriage. Seek urgent review for heavy bleeding or instability. |
| Definite retained intrauterine pregnancy tissue with no adnexal mass | Supports incomplete miscarriage. Endometrial thickness alone cannot confirm it. |
| Empty uterus after bleeding, with prior ultrasound evidence of intrauterine pregnancy or retained intrauterine tissue | A widest endometrial thickness under 15 mm supports complete miscarriage under the Irish guideline. Without previous location confirmation, arrange PUL follow-up. |
| Intrauterine pregnancy with absent cardiac activity meeting diagnostic scan criteria | Missed miscarriage can occur with little or no bleeding. |
| Fever, uterine tenderness, offensive discharge or evidence of septic shock | Consider septic miscarriage. Start urgent sepsis assessment, antibiotics and specialist source control. |
Under the Irish 2025 miscarriage guideline, a crown–rump length of at least 7 mm on adequate TVUS with no cardiac activity meets a missed miscarriage criterion. On transabdominal imaging the corresponding threshold is greater than 8 mm. For a genuinely empty intrauterine sac, a mean sac diameter of at least 25 mm meets the Irish empty-sac criterion on transvaginal or transabdominal imaging. Apply the full guideline and seek clarification for uncertain sac contents or measurements. If the findings are below thresholds for confirmation and the intrauterine pregnancy is of uncertain viability, repeat the scan after 7–10 days. Seek a second opinion and/or a repeat scan when there is uncertainty about the measurements or findings. The last menstrual period and loss of pregnancy symptoms alone cannot establish non-viability. Explain the results and options sensitively.
Managing confirmed first-trimester miscarriage
Offer clinically appropriate options and explain expected bleeding and pain, limits to home care and how to seek urgent help for heavy or prolonged bleeding, faintness, fever or severe symptoms.
- Expectant care: The Irish pathway offers about two weeks when stable and without infection or major haemorrhage risk. Arrange ultrasound two weeks after bleeding stops, or a high-sensitivity urine pregnancy test three weeks after bleeding stops if clinically well and ultrasound follow-up is declined. Persistent heavy or abnormal bleeding needs urgent review.
- Medical care: For a confirmed missed miscarriage, the Irish guideline uses mifepristone 200 mg orally, followed 24–48 hours later (ideally 36) by misoprostol 800 micrograms buccally or vaginally. In incomplete miscarriage, the appendix uses misoprostol 800 micrograms buccally or vaginally alone. After outpatient treatment use a high-sensitivity urine test or ultrasound at three weeks. Contact the unit if bleeding has not started within 48 hours after misoprostol, symptoms worsen or the follow-up test is positive.
- Surgical care: Suction evacuation can be selected by preference or after unsuccessful conservative or medical care. Manual vacuum aspiration under local anaesthesia may be suitable for selected patients. Instability, persistent excessive bleeding, infection or suspected gestational trophoblastic disease requires urgent specialist management. With suspected septic miscarriage give prompt broad-spectrum IV antibiotics and arrange source control.
Suspect molar pregnancy when the early scan shows abnormal cystic intrauterine tissue or when bleeding, severe vomiting or disproportionate hCG raises concern in combination with the clinical and imaging findings. Presentation varies, especially with partial mole, and diagnosis relies on examination of tissue. Arrange specialist surgical management, alert pathology to the suspicion and register suspected gestational trophoblastic disease with the Irish national centre. Serial serum hCG after evacuation follows the national centre’s plan and differs between complete and partial mole. A persistently abnormal trend needs specialist assessment.
Anti-D immunoglobulin in early pregnancy
Offer anti-D to unsensitised RhD-negative patients undergoing surgical management of first-trimester miscarriage or any type of ectopic pregnancy. Under the Irish 2025 miscarriage guideline, routine prophylaxis is unnecessary in expectant or medical management of first-trimester miscarriage. Consider it for repetitive heavy bleeding or bleeding with pain when the pregnancy is confirmed beyond ten weeks. Under the Irish 2024 ectopic guideline, discuss the option in medical or expectant management of tubal ectopic pregnancy because guidance differs. Select the preparation and dose with the local maternity and transfusion protocol. The late-pregnancy fetomaternal haemorrhage testing pathway is a separate decision.
Irish first-trimester miscarriage guideline · Irish ectopic pregnancy guideline
A haemodynamically stable patient with minimal discomfort has an expert transvaginal scan showing a 24 mm right tubal gestational sac with a yolk sac, separate from the ovary. No embryonic cardiac activity or haemoperitoneum is seen. Beta-hCG is 2,400 IU/L. Her full blood count, kidney and liver function are satisfactory. She has no contraindications to methotrexate, can complete surveillance, and prefers medical treatment after consultant counselling. What plan is appropriate?
Give IM methotrexate 50 mg/m² and measure beta-hCG on days 4 and 7
Arrange emergency laparotomy for haemodynamic collapse
Discharge with reassurance and repeat ultrasound only in two weeks
Give misoprostol alone for an intrauterine miscarriage
A 24-year-old with a positive pregnancy test and recent spotting is now pain-free and haemodynamically stable. Expert transvaginal ultrasound shows neither an intrauterine nor an extrauterine pregnancy. Serum beta-hCG increases from 820 to 1,025 IU/L over 48 hours. What is the best interpretation and plan under the Irish pregnancy-of-unknown-location pathway?
Accept a viable intrauterine pregnancy and defer surveillance until beta-hCG exceeds 5,000 IU/L
Recognise a higher-risk trend, continue the pregnancy-of-unknown-location pathway and arrange further beta-hCG, senior input and repeat expert imaging as indicated
Diagnose a complete miscarriage and discharge without further surveillance
Diagnose an ectopic pregnancy from the percentage rise and give methotrexate immediately
At an early pregnancy assessment unit, an appropriately qualified clinician performs a technically adequate transvaginal scan and clearly sees an intrauterine embryo with a crown–rump length of 11 mm and absent cardiac activity. The patient has no pain, bleeding or signs of infection. After counselling about the findings and options, she chooses medical care. Which diagnosis and regimen match the Irish first-trimester guideline?
Threatened miscarriage, managed with strict bed rest
Complete miscarriage, managed with tranexamic acid
Missed miscarriage, treated with oral mifepristone 200 mg followed 24–48 hours later by misoprostol 800 micrograms buccally or vaginally
Pregnancy of unknown location, treated with methotrexate
Sections you finish are checked off in the contents.